The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, Ad26.COV2.S, developed by Johnson & Johnson’s subsidiary, Janssen Biotech. This marks the third vaccine authorized by the FDA to combat COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Details of the Authorization: The […]
Palforzia FDA approval : Aimmune Therapeutics has been granted approval from the US Food and Drug Administration (FDA) for Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for the treatment of peanut allergy in children. The peanut allergy drug has been approved for mitigating allergic reactions such as anaphylaxis, that may result from accidental exposure to peanuts, […]
